Found 48 matching trials
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
PHASE4This study aims to assess the neutralizing antibody levels and prevalence r...
Status
Active Not Recruiting
Location
Liaoning Provincial Center for Disease Control and Prevention
Immunogenicity of SA 14-14-2 JE Vaccine
PHASE4The proposed Japanese Encephalitis (JE)Vaccine study is a four-arm double-b...
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
PHASE2Safety:
To describe the safety profiles following vaccination.
Immunogeni...
Location
Multiple Locations
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers
PHASE2This study evaluated the safety and immunogenicity of rabies vaccine and Ja...
Location
Tropical Medicine, Mahidol University
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX
PHASE4This study was undertaken to assess the immunogenicity and safety of a boos...
Location
Multiple Locations
Post-licensure Safety Study of IMOJEV® in Thailand
PHASE4The aim of this study is to further characterize the safety profile of IMOJ...
Location
Multiple Locations
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
PHASE3Japanese encephalitis (JE) is the main cause of viral encephalitis in many ...
Location
Department Tropical Pediatrics
Safety Surveillance After Immunization With IXIARO
N/AThis is an active electronic surveillance using data from the Defense Medic...
Location
Military Vaccine Agency
Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
PHASE3The old mouse brain derived Japanese encephalitis vaccines (MBJEV) have bee...
Location
Multiple Locations
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
PHASE2The purpose of this study is to determine non-inferiority in seroconversion...
Location
Clinical Pharamacology Center